Work

Blood-Based Neuroendocrine Tumor mRNA Signature Identifies Residual Disease and at Day 30 after Operation Predicts Tumor Recurrence with 98% Specificity

Year: 2020

Type: article

Source: Journal of the American College of Surgeons

DOI: 10.1016/j.jamcollsurg.2020.08.129

Authors: Irvin M. Modlin, Mark Kidd, Massimo Falconi, Andrea Frilling, Anna Malczewska, Ignat A. Drozdov, Alexandra Kitz

Institutions: Medical University of Silesia, Yale University, IRCCS Ospedale San Raffaele, Wren Laboratories (United States), Imperial College London

Language: English

Topic: Neuroendocrine Tumor Research Advances

Subfield: Epidemiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3090934790

FWCI:

Cites:

Cited by:

Related to: 10